Your browser doesn't support javascript.
loading
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma.
Kedmi, Meirav; Shouval, Roni; Fried, Shalev; Bomze, David; Fein, Joshua; Cohen, Zachary; Danilesko, Ivetta; Shem-Tov, Noga; Yerushalmi, Ronit; Jacoby, Elad; Besser, Michal; Shimoni, Avichai; Nagler, Arnon; Avigdor, Abraham.
Afiliação
  • Kedmi M; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Israel. Electronic address: Meirav.kedmi@sheba.he
  • Shouval R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill
  • Fried S; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Bomze D; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Fein J; University of Connecticut Medical Center, Farmington, Connecticut.
  • Cohen Z; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Danilesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Jacoby E; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Division of Pediatric Hematology, Oncology and BMT, Chaim Sheba Medical Center, The Edmond and Lily Safra Children's Hospital, Tel-Hashomer, Israel.
  • Besser M; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel-Aviv, Israel; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Transplant Cell Ther ; 28(5): 251-257, 2022 05.
Article em En | MEDLINE | ID: mdl-35218999
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Etiology_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Etiology_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article